NovaBridge Biosciences NBP
NASDAQ NBP
$1.38 -0.05 (-3.51%)
As of: Oct 21, 2026 · 3:57 PM EDT

NovaBridge Biosciences (NBP) Net Cash Flow (2019 - 2025)

Updated

NovaBridge Biosciences (NBP) posted Net Cash Flow of -$75.34 million for Q4 2025, compared with -$14.79 million a year earlier.

Analysis

NovaBridge Biosciences (NBP) Net Cash Flow (2019 - 2025) Analysis & Trends

For FY2025, NovaBridge Biosciences' Net Cash Flow came in at -$20.6 million.

  • In prior years, NovaBridge Biosciences' Net Cash Flow was -$79.13 million in FY2024, -$169.08 million in FY2023, -$89.67 million in FY2022 and -$171.53 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 3.72 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -1.27 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -2.82 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 1.53 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 757.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -3.94 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 1.95 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -4.43 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -722.00 Mn
10 NovaBridge Biosciences 131.20 Mn -664.38 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -17.62 Mn
Sep 30, 2025 62.59 Mn
Dec 31, 2024 -11.06 Mn
Sep 30, 2024 -73.23 Mn
Dec 31, 2020 289.03 Mn
Sep 30, 2020 239.14 Mn
Dec 31, 2019 -3.60 Mn
API Access

NovaBridge Biosciences Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=NBP&period=max&api_key=YOUR_API_KEY